Clinical Trial Update: A Study of Tobramycin Inhalation Powder From a Modified Manufacturing Process Versus Placebo [Phase 3]

View source ↗

Summary

This Phase 3 trial compared Tobramycin Inhalation Powder from a modified manufacturing process with placebo in cystic fibrosis, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Tobramycin Inhalation Powder (tobramycin inhalation powder)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Cystic Fibrosis | Phase 3 | Status: COMPLETED | Results posted: 2012-10-03